Cargando…

Molecular targeted therapies in metastatic melanoma

The advent of personalized medicine has ushered in a new era for cancer therapy with a significant impact on the management of advanced melanoma. Molecular targeted therapies have shown promise in the management of various malignancies, including melanoma, with lower toxicity profiles and better ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Rima, Wieland, Carilyn N, Comfere, Nneka I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702032/ https://www.ncbi.nlm.nih.gov/pubmed/23843700 http://dx.doi.org/10.2147/PGPM.S44800

Ejemplares similares

Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies
por: Rager, Taylor, et al.
Publicado: (2022)

Trametinib: A Targeted Therapy in Metastatic Melanoma
por: Hoffner, Brianna, et al.
Publicado: (2018)

Rates of provision of clinical information in the skin biopsy requisition form and corresponding encounter visit note
por: Olson, Meredith A., et al.
Publicado: (2016)

Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma
por: Keller, Hilary R., et al.
Publicado: (2017)

Resistance to Molecularly Targeted Therapies in Melanoma
por: Patel, Meet, et al.
Publicado: (2021)

Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
por: Kim, Teresa, et al.
Publicado: (2014)

Quality improvement and healthcare: The Mayo Clinic quality Academy experience
por: Comfere, Nneka I., et al.
Publicado: (2020)

Electrochemotherapy and Other Clinical Applications of Electroporation for the Targeted Therapy of Metastatic Melanoma
por: Cucu, Corina Ioana, et al.
Publicado: (2021)

Targeted agents for the treatment of metastatic melanoma
por: Monzon, Jose G, et al.
Publicado: (2012)

Therapy for metastatic melanoma: the past, present, and future
por: Finn, Laura, et al.
Publicado: (2012)

Chemokines as possible therapeutic targets in metastatic melanoma
por: Basson, Charlise, et al.
Publicado: (2023)

Cholesterol Embolization Syndrome Post Invasive Arterial Procedure: A Case Report
por: Akpala, Christeebella, et al.
Publicado: (2023)

Systemic Therapy of Non-Resectable Metastatic Melanoma
por: Orouji, Azadeh, et al.
Publicado: (2010)

Systemic Therapy of Metastatic Melanoma: On the Road to Cure
por: Steininger, Julian, et al.
Publicado: (2021)

Interprofessional collaboration milestones: advocating for common assessment criteria in graduate medical education
por: Wingo, Majken T., et al.
Publicado: (2015)

Uses of Mobile Device Digital Photography of Dermatologic Conditions in Primary Care
por: Pecina, Jennifer L, et al.
Publicado: (2017)

Langerhans cell activation in diabetic small fiber polyneuropathy
por: Piccione, Ezequiel Agustin, et al.
Publicado: (2014)

Drug targets and predictive biomarkers in the management of metastatic melanoma
por: Thumar, Jaykumar, et al.
Publicado: (2012)

Targeted therapy in melanoma
por: Tawbi, Hussein, et al.
Publicado: (2009)

Molecular Markers and Targets in Melanoma
por: Teixido, Cristina, et al.
Publicado: (2021)

BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge
por: Florent, Laetitia, et al.
Publicado: (2023)

Molecular targeted therapy for advanced or metastatic soft tissue sarcoma
por: Yuan, Jin, et al.
Publicado: (2021)

Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma
por: Mallone, Fabiana, et al.
Publicado: (2020)

Novel Drugs and Combination Therapies for the Treatment of Metastatic Melanoma
por: Vennepureddy, Adarsh, et al.
Publicado: (2016)

Photodynamic Therapy for Metastatic Melanoma Treatment: A Review
por: Naidoo, Channay, et al.
Publicado: (2018)

TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma
por: Strobel, Sophia B., et al.
Publicado: (2022)

Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor
por: Zhang, Chengcheng, et al.
Publicado: (2017)

Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance
por: Wagstaff, William, et al.
Publicado: (2022)

Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
por: Yu, Chune, et al.
Publicado: (2019)

Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma
por: Becquart, Ondine, et al.
Publicado: (2021)

Lipoid proteinosis: Unfamiliar skin findings delay diagnosis
por: Larkin, Sydney, et al.
Publicado: (2018)

Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature
por: PosthumaDeBoer, J., et al.
Publicado: (2011)

The Role of Radiation Therapy in the Management of Metastatic Melanoma in the Brain
por: Hong, Angela, et al.
Publicado: (2012)

Melanogenesis and the Targeted Therapy of Melanoma
por: Li, Cang, et al.
Publicado: (2022)

Advances in Natural or Synthetic Nanoparticles for Metastatic Melanoma Therapy and Diagnosis
por: Arasi, Maria Beatrice, et al.
Publicado: (2020)

Looking into a Better Future: Novel Therapies for Metastatic Melanoma
por: Villani, Alessia, et al.
Publicado: (2021)

Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies
por: Gkiala, Anastasia, et al.
Publicado: (2020)

Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
por: Cirenajwis, Helena, et al.
Publicado: (2015)

Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma
por: ERIKSSON, Hanna, et al.
Publicado: (2020)

Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges
por: Sorrentino, Carlo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n1rlqvlts5016r1p006i6bspv8